Disruptive Pharma AB (publ) (STO:GUARD)

Sweden · Delayed Price · Currency is SEK

1.292

-0.036 (-2.71%)

Aug 13, 2026, 4:36 PM CET

Disruptive Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	11.69	11.74	9.92	9.15	8.82	5.96
Research & Development	69.27	96	90.33	105.77	104.81	75.33
Other Operating Expenses	0.2	-0.54	-0.34	0.15	1.29	0.62
Total Operating Expenses	81.16	107.2	99.91	115.07	114.92	81.9
Operating Income	-80.98	-107.2	-99.91	-115.07	-114.92	-81.9
Interest Income	0.64	0.58	3.85	2.2	2.08	0.02
Interest Expense	-0.64	-2.23	-0.01	-0.45	-0	-0.15
Total Non-Operating Income (Expense)	-0.01	-1.66	3.84	1.75	2.08	-0.13
Pretax Income	-80.99	-108.85	-96.07	-113.32	-112.84	-82.03
Net Income	-80.99	-108.85	-96.07	-113.32	-112.84	-82.03
Net Income to Common	-80.99	-108.85	-96.07	-113.32	-112.84	-82.03
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	20	18	11	10	7	4
Shares Outstanding (Diluted)	20	18	11	10	7	4
Shares Change	70.67%	61.72%	10.82%	42.77%	57.95%	34.53%
EPS (Basic)	-4.07	-6.04	-8.62	-11.26	-16.01	-18.50
EPS (Diluted)	-4.07	-6.04	-8.62	-11.26	-16.01	-18.50
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-82.35	-109.35	-94.75	-116.05	-102.14	-77.59
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-4.12	-6.06	-8.50	-11.53	-14.49	-17.39
EBITDA	-80.98	-107.2	-99.91	-115.07	-114.92	-81.9
EBIT	-80.98	-107.2	-99.91	-115.07	-114.92	-81.9